Which of the following describes the dosing for Fycompa (perampanel)?

Fycompa (perampanel) is an antiepileptic medication primarily used in the treatment of epilepsy. The recommended dosing schedule for this medication is a single daily dose. This is particularly advantageous for patients because it simplifies adherence to the treatment regimen, minimizing the potential complications of managing multiple doses throughout the day.

Once daily dosing allows for a stable and consistent level of the medication in the bloodstream, which is important in effectively controlling seizures while also promoting better patient compliance. The formulation and pharmacokinetics of perampanel are designed to support this dosing schedule, making it an effective choice for long-term management in patients with epilepsy.

In contrast, the other dosing regimens listed, such as twice daily, every other day, or weekly, do not align with the established recommendations for this specific medication. This ensures that patients receive the optimal therapeutic effect while minimizing the risk of missed doses or fluctuations in drug levels that could lead to seizure breakthrough or side effects.